Bristol Myers Squibb nabs priority review tag for $3.15B arthritis drug Orencia to prevent transplant rejection fkansteiner Mon, 08/23/2021 – 11:23 More: Bristol Myers Squibb nabs priority review tag for .15B arthritis drug Orencia to prevent transplant rejection Source: fierce
read moreESC: Amarin touts Vascepa’s ability to reduce repeat heart problems as it fights generic with ‘skinny label’ claim aliu Mon, 08/23/2021 – 11:17 More: ESC: Amarin touts Vascepa's ability to reduce repeat heart problems as it fights generic with 'skinny
read morePfizer, BioNTech score FDA’s first full COVID-19 vaccine nod, quickly triggering stricter mandates nhigginsdunn Mon, 08/23/2021 – 10:59 More: Pfizer, BioNTech score FDA's first full COVID-19 vaccine nod, quickly triggering stricter mandates Source: fierce
read moreAfter vandalism during unrest in South Africa, India-based Cipla reopens Durban manufacturing site kdunleavy Mon, 08/23/2021 – 09:59 More: After vandalism during unrest in South Africa, India-based Cipla reopens Durban manufacturing site Source: fierce
read moreNICE decision also extends treatment to people aged up to 22 years old More: Kuvan approved for pregnant women with PKU in UK Source: News
read moreTalazoparib delayed disease progression in Phase II trial More: New BRCA-targeting drug could treat advanced prostate cancer Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals